Fracture Liaison Services crucial for addressing global osteoporosis challenges

A new Perspective article published in the New England Journal of Medicine emphasizes the critical role of Fracture Liaison Services (FLS) in addressing the growing global burden of osteoporosis-related fractures, particularly hip fractures.

Bristol ‘take-under’ of Mirati is not so great for biotech, but company’s new cancer target has potential

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics: A take-under deal feels meh for biotech sector sentiment. Bristol is paying $58 per share

October 9, 2023

FDA asks for more data on Dupixent in COPD in move that could delay a decision

The FDA wants more info on Regeneron and Sanofi’s blockbuster Dupixent before it decides whether to approve the treatment for some patients with chronic obstructive

May 3, 2024

Preventive drugs may be the best solution to the antibiotic resistance crisis

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.